Skip to main content
Log in

Longitudinal measures in children receiving ENCAD for hereditary retinal degeneration

  • Published:
Documenta Ophthalmologica Aims and scope Submit manuscript

Abstract

A hydrolysate of yeast RNA (ENCAD) is used in the Soviet Union for the treatment of hereditary retinal degenerations. We report longitudinal data from three young patients who have made at least two visits to the Soviet Union over a five-year period to receive treatment with ENCAD. Two children were diagnosed with cone-rod degeneration and the third has an isolated (simplex) form of retinitis pigmentosa. Visual function measurements were obtained before and after each visit to Moscow. In the comparison of previsit and postvisit visual acuity, 30 Hz flicker amplitude, and visual fields, ENCAD treatment had no significant short-term effect. Despite treatment with ENCAD, each patient has shown a significant decrease in visual function over the 5-year period. The rate of progression in these patients appears similar to previously published data on the natural history of their retinal degenerative disorders.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

ENCAD:

a hydrolysate of yeast RNA

RP:

retinitis pigmentosa

References

  1. Heckenlively JR. The diagnosis and classification of retinitis pigmentosa. In: Heckenlively JR, ed. Retinitis pigmentosa. Philadelphia: JB Lippincott, 1988: 21.

    Google Scholar 

  2. Katznelson LA, Khoroshilova-Maslova IP, Eliseyeva RF. A new method of treatment of retinitis pigmentosa/pigmentary abiotrophy. Ann Ophthalmol 1990; 22: 167–72.

    Google Scholar 

  3. McManus EH, Hartenstine DL, Laties AM, Berson EL. Summary of exchange visit to the Helmhotz Institute of Ophthalmology. Bethesda, MD: National Eye Institute, 1983.

    Google Scholar 

  4. Berson EL, Rosen JB, Simonoff EA. Electroretinographic testing as an aid in detection of carriers of X-chromosome-linked retinitis pigmentosa. Am J Ophthalmol 1979; 87: 460–68.

    Google Scholar 

  5. Dagnelie G. Conversion of planimetric visual field data into solid angles and retinal areas. Clin Vis Sci 1990; 5: 95–100.

    Google Scholar 

  6. Berson EL, Sandberg MA, Rosner B, Birch DG, Hanson AH: Natural course of retinitis pigmentosa. Am J Ophthalmol 1985; 99: 240–51.

    Google Scholar 

  7. Marmor MF, Aguirre G, Arden G, Nilsson SEG, Zrenner E. Standard for clinical electroretinography. Arch Ophthalmol 1989; 107: 816–19.

    Google Scholar 

  8. Andreasson SOL, Sandberg MA, Berson EL. Narrow-band filtering for monitoring low-amplitude cone electroretinograms in retinitis pigmentosa. Am J. Ophthalmol 1988; 105: 500–503.

    Google Scholar 

  9. Birch DG, Fish GE. Rod ERGs in retinitis pigmentosa and cone-rod degeneration. Invest Ophthalmol Vis Sci 1987; 28: 140–50.

    Google Scholar 

  10. Birch DG, Anderson JL. Rod visual fields in cone-rod degeneration: comparisons to retinitis pigmentosa. Invest Ophthalmol Vis Sci 1990; 31: 2288–99.

    Google Scholar 

  11. Massof RW, Dagnelie G, Benzschawal T, Palmer RW, Finkelstein D. First order dynamics of visual field loss in retinitis pigmentosa. Clin Vis Sci 1990; 5: 1–26.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Birch, D.G., Anderson, J.L. & Fish, G.E. Longitudinal measures in children receiving ENCAD for hereditary retinal degeneration. Doc Ophthalmol 77, 185–192 (1991). https://doi.org/10.1007/BF00161366

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00161366

Key words

Navigation